Dendritic Cell Vaccination for Patients with Solid Tumors

Clinical trial NCT01291420 · COMPLETED

Trial details

NCT number: NCT01291420
Sponsor: University Hospital, Antwerp
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Renal Cell Carcinoma Sarcomas Breast Cancers Malignant Mesothelioma Colorectal Tumors

Start date: 2010-05-03
Primary completion: 2016-04-25
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.